Follow the Enorama Pharma AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, Enorama Pharma AB has recorded 0 public disclosures. Market capitalisation: €24.6m. The full history is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Enorama Pharma AB is a company focused on developing innovative pharmaceutical products, particularly in the area of addiction treatments. It is listed on the Stockholm Stock Exchange.